We are the first publicly-traded biotech or pharmaceutical company to take the form of a public benefit corporation. Our public benefit purpose is to provide a brighter future for patients through the development of novel pharmaceutical therapies; and technologies that expand the availability of transplantable organs. United Therapeutics (Nasdaq: UTHR) seeks to travel down the corridors of indifference to develop treatments for rare, deadly diseases. We were founded in 1996 by a family seeking a cure for their daughter's pulmonary arterial hypertension (PAH). Today, we have six FDA-approved therapies that treat PAH, pulmonary hypertension associated with interstitial lung disease (PH-ILD) and neuroblastoma, a rare pediatric cancer. Our near-term pipeline seeks to develop additional therapies for PAH and pulmonary fibrosis (PF). The cure for end-stage life-threatening diseases like PAH, PH-ILD, PF, and many others is an organ transplant, but only a small percentage of donated organs are available to address the vast need. For this reason, we are working to create bio-artificial organs to address the shortage of kidneys, hearts, lungs, and livers available for transplant. We believe an unlimited supply of tolerable, transplantable organs will eliminate the transplant waiting list and cure end-stage organ diseases for which transplant is not currently an option.
The selected intern will need to report onsite at the Silver Spring, MD office for the entire duration of the program which runs from May through August 2026. United Therapeutics does not provide housing or transportation. A stipend for relocation assistance may be provided on a case-by-case basis.
Program Highlights:
Our internships provide a unique opportunity for individuals to work with some of the most talented people within the pharmaceutical and biotech industry. Our onsite locations offer a variety of amenities and perks available to all our interns. Addition highlights include:
Program Details:
How you'll contribute UT's computational systems biology lab in Silver Spring, MD is building an in silico model of the lung to support drug development and organ manufacturing. In this role you will play an important role in supporting mathematical models of molecular and physiological processes that regulate lung function, disease, and drug response.
For this role you will need Minimum Requirements:
Eligible employees may participate in the Company's comprehensive benefits suite of programs, including medical / dental / vision / prescription coverage, employee wellness resources, savings plans (401k and ESPP), paid time off & paid parental leave benefits, disability benefits, and more.
United Therapeutics Corporation is an Equal Opportunity Employer, including veterans and individuals with disabilities.